Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 14 | 2025 | 72 | 4.680 |
Why?
|
| Escherichia coli | 24 | 2023 | 338 | 4.640 |
Why?
|
| Anti-Bacterial Agents | 21 | 2025 | 534 | 4.440 |
Why?
|
| Escherichia coli Proteins | 17 | 2021 | 118 | 3.840 |
Why?
|
| Adenosine Triphosphatases | 10 | 2022 | 50 | 3.520 |
Why?
|
| Multiprotein Complexes | 9 | 2022 | 54 | 3.360 |
Why?
|
| Chromosomal Proteins, Non-Histone | 12 | 2021 | 79 | 3.040 |
Why?
|
| Chromosomes, Bacterial | 10 | 2020 | 20 | 2.980 |
Why?
|
| Gram-Negative Bacteria | 12 | 2023 | 62 | 2.780 |
Why?
|
| DNA-Binding Proteins | 9 | 2022 | 490 | 2.760 |
Why?
|
| Chromosome Segregation | 9 | 2024 | 57 | 2.750 |
Why?
|
| Membrane Transport Proteins | 9 | 2025 | 79 | 2.710 |
Why?
|
| DNA, Bacterial | 12 | 2020 | 309 | 2.590 |
Why?
|
| Repressor Proteins | 8 | 2018 | 119 | 1.910 |
Why?
|
| Bacterial Proteins | 8 | 2025 | 491 | 1.780 |
Why?
|
| Nucleic Acid Conformation | 11 | 2017 | 90 | 1.390 |
Why?
|
| DNA | 6 | 2021 | 375 | 1.350 |
Why?
|
| Bacterial Outer Membrane Proteins | 7 | 2021 | 101 | 1.330 |
Why?
|
| Pseudomonas Infections | 2 | 2022 | 25 | 1.230 |
Why?
|
| Models, Biological | 8 | 2021 | 468 | 0.990 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 4 | 2021 | 29 | 0.960 |
Why?
|
| DNA Replication | 4 | 2018 | 51 | 0.950 |
Why?
|
| DNA, Superhelical | 8 | 2005 | 9 | 0.840 |
Why?
|
| Cell Cycle Proteins | 2 | 2021 | 187 | 0.740 |
Why?
|
| Origin Recognition Complex | 1 | 2020 | 2 | 0.670 |
Why?
|
| Microbial Sensitivity Tests | 8 | 2024 | 148 | 0.610 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 19 | 0.580 |
Why?
|
| Biological Transport | 8 | 2023 | 124 | 0.540 |
Why?
|
| Novobiocin | 2 | 2017 | 16 | 0.530 |
Why?
|
| DNA Topoisomerases | 1 | 2016 | 2 | 0.500 |
Why?
|
| Gene Expression Regulation, Bacterial | 5 | 2025 | 158 | 0.470 |
Why?
|
| Chromosome Structures | 1 | 2014 | 2 | 0.440 |
Why?
|
| Cell Membrane | 4 | 2022 | 259 | 0.430 |
Why?
|
| Chromatin | 1 | 2015 | 76 | 0.430 |
Why?
|
| Genome, Bacterial | 1 | 2014 | 72 | 0.420 |
Why?
|
| Binding Sites | 4 | 2021 | 354 | 0.420 |
Why?
|
| Magnesium Chloride | 3 | 1997 | 7 | 0.400 |
Why?
|
| Sodium Chloride | 3 | 1997 | 67 | 0.390 |
Why?
|
| Magnetics | 1 | 2012 | 14 | 0.380 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2012 | 24 | 0.380 |
Why?
|
| Kinetics | 6 | 2021 | 551 | 0.350 |
Why?
|
| Lipids | 1 | 2012 | 214 | 0.340 |
Why?
|
| DNA, Catenated | 1 | 2009 | 1 | 0.320 |
Why?
|
| Permeability | 5 | 2023 | 61 | 0.320 |
Why?
|
| Protein Binding | 6 | 2021 | 664 | 0.300 |
Why?
|
| Nanoparticles | 1 | 2012 | 291 | 0.290 |
Why?
|
| Point Mutation | 2 | 2021 | 60 | 0.270 |
Why?
|
| DNA Topoisomerases, Type II | 4 | 2009 | 14 | 0.270 |
Why?
|
| Models, Molecular | 7 | 2021 | 452 | 0.260 |
Why?
|
| Adenosine Triphosphate | 5 | 2011 | 121 | 0.250 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2006 | 13 | 0.250 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2021 | 38 | 0.250 |
Why?
|
| Virulence | 2 | 2025 | 152 | 0.230 |
Why?
|
| Magnetic Phenomena | 2 | 2017 | 7 | 0.230 |
Why?
|
| Plasmids | 5 | 2016 | 126 | 0.220 |
Why?
|
| DNA, Circular | 3 | 2001 | 5 | 0.210 |
Why?
|
| Computer Simulation | 5 | 2017 | 231 | 0.200 |
Why?
|
| Lipoproteins | 2 | 2017 | 99 | 0.200 |
Why?
|
| Oxazolidinones | 1 | 2022 | 4 | 0.190 |
Why?
|
| Humans | 9 | 2022 | 28585 | 0.190 |
Why?
|
| Molecular Docking Simulation | 2 | 2021 | 52 | 0.190 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2021 | 177 | 0.190 |
Why?
|
| Cell Wall | 1 | 2022 | 67 | 0.190 |
Why?
|
| Biotinylation | 1 | 2021 | 19 | 0.180 |
Why?
|
| Virulence Factors | 1 | 2022 | 45 | 0.180 |
Why?
|
| Protein Domains | 1 | 2021 | 53 | 0.180 |
Why?
|
| Life Style | 1 | 2022 | 90 | 0.180 |
Why?
|
| Phagocytosis | 1 | 2021 | 80 | 0.170 |
Why?
|
| Cell Communication | 1 | 2021 | 68 | 0.170 |
Why?
|
| Peptidomimetics | 1 | 2021 | 3 | 0.170 |
Why?
|
| Fluoroquinolones | 1 | 2021 | 15 | 0.170 |
Why?
|
| Membrane Lipids | 1 | 2021 | 22 | 0.170 |
Why?
|
| Gram-Positive Bacteria | 1 | 2021 | 33 | 0.170 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 41 | 0.170 |
Why?
|
| Biofilms | 1 | 2022 | 122 | 0.170 |
Why?
|
| Vocabulary | 1 | 2020 | 7 | 0.170 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2021 | 115 | 0.160 |
Why?
|
| Porins | 2 | 2017 | 13 | 0.160 |
Why?
|
| DNA Topoisomerase IV | 2 | 2016 | 4 | 0.160 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 249 | 0.160 |
Why?
|
| Replication Origin | 1 | 2018 | 6 | 0.150 |
Why?
|
| Naphthalenes | 1 | 2018 | 17 | 0.150 |
Why?
|
| Isoquinolines | 1 | 2018 | 15 | 0.150 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 57 | 0.150 |
Why?
|
| Genes, Reporter | 1 | 2018 | 87 | 0.140 |
Why?
|
| Cinnamates | 1 | 2017 | 6 | 0.140 |
Why?
|
| Benzimidazoles | 1 | 2017 | 32 | 0.130 |
Why?
|
| DNA, Viral | 2 | 1997 | 63 | 0.130 |
Why?
|
| Imidazoles | 1 | 2017 | 63 | 0.130 |
Why?
|
| Genes, MDR | 1 | 2016 | 6 | 0.130 |
Why?
|
| DNA Gyrase | 1 | 2016 | 6 | 0.120 |
Why?
|
| Animals | 4 | 2019 | 10583 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2017 | 252 | 0.120 |
Why?
|
| Protein Multimerization | 2 | 2012 | 57 | 0.110 |
Why?
|
| Genomic Instability | 1 | 2014 | 34 | 0.110 |
Why?
|
| Cell Division | 1 | 2014 | 154 | 0.110 |
Why?
|
| Cell Differentiation | 1 | 2016 | 419 | 0.100 |
Why?
|
| Coliphages | 1 | 1993 | 2 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2012 | 26 | 0.100 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 93 | 0.100 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2005 | 26 | 0.090 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2005 | 40 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 404 | 0.090 |
Why?
|
| Monte Carlo Method | 3 | 1997 | 62 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 1602 | 0.090 |
Why?
|
| Operon | 1 | 2011 | 40 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2011 | 44 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 133 | 0.090 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 130 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2011 | 126 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 166 | 0.080 |
Why?
|
| Microscopy, Electron | 3 | 2005 | 94 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 376 | 0.080 |
Why?
|
| Time Factors | 1 | 2013 | 1600 | 0.080 |
Why?
|
| Thermodynamics | 2 | 2021 | 93 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2021 | 209 | 0.070 |
Why?
|
| DNA Topoisomerases, Type I | 3 | 2002 | 7 | 0.070 |
Why?
|
| Spermidine | 2 | 1997 | 6 | 0.070 |
Why?
|
| Erythromycin | 2 | 2017 | 15 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 101 | 0.070 |
Why?
|
| Gene Expression | 2 | 2021 | 417 | 0.070 |
Why?
|
| Cell Membrane Permeability | 2 | 2017 | 44 | 0.070 |
Why?
|
| Mice | 1 | 2016 | 4735 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2007 | 138 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 163 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 233 | 0.060 |
Why?
|
| Adenylyl Imidodiphosphate | 1 | 2005 | 2 | 0.060 |
Why?
|
| Acyl Carrier Protein | 1 | 2005 | 3 | 0.060 |
Why?
|
| Chromatography | 1 | 2005 | 9 | 0.060 |
Why?
|
| Sepharose | 1 | 2005 | 14 | 0.060 |
Why?
|
| Sucrose | 1 | 2005 | 27 | 0.060 |
Why?
|
| Dimerization | 1 | 2005 | 76 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2005 | 67 | 0.060 |
Why?
|
| Molecular Weight | 1 | 2005 | 122 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2009 | 485 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2005 | 125 | 0.060 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1997 | 12 | 0.060 |
Why?
|
| Heparin | 1 | 2005 | 111 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 611 | 0.050 |
Why?
|
| Linezolid | 1 | 2022 | 4 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 1 | 2022 | 36 | 0.050 |
Why?
|
| Amides | 1 | 2021 | 19 | 0.040 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2021 | 19 | 0.040 |
Why?
|
| Hydrolysis | 2 | 1999 | 60 | 0.040 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2021 | 4 | 0.040 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2021 | 6 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 25 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 51 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2016 | 415 | 0.040 |
Why?
|
| Female | 1 | 2016 | 15472 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 91 | 0.040 |
Why?
|
| Chromosomes | 1 | 1999 | 59 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 17 | 0.040 |
Why?
|
| Burkholderia cepacia | 1 | 2017 | 5 | 0.030 |
Why?
|
| Diffusion | 1 | 2017 | 39 | 0.030 |
Why?
|
| Myoviridae | 1 | 1997 | 1 | 0.030 |
Why?
|
| Acinetobacter baumannii | 1 | 2017 | 14 | 0.030 |
Why?
|
| Databases, Chemical | 1 | 2017 | 3 | 0.030 |
Why?
|
| Chemistry, Physical | 1 | 1997 | 13 | 0.030 |
Why?
|
| Algorithms | 1 | 2020 | 430 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1997 | 27 | 0.030 |
Why?
|
| Chemical Phenomena | 1 | 1997 | 22 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 104 | 0.030 |
Why?
|
| Static Electricity | 1 | 1997 | 35 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 1997 | 62 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2017 | 44 | 0.030 |
Why?
|
| Models, Chemical | 1 | 1997 | 90 | 0.030 |
Why?
|
| Arabinose | 1 | 2016 | 4 | 0.030 |
Why?
|
| Transformation, Bacterial | 1 | 2016 | 13 | 0.030 |
Why?
|
| Particle Size | 1 | 1997 | 105 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2016 | 24 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2016 | 37 | 0.030 |
Why?
|
| Vancomycin | 1 | 2016 | 58 | 0.030 |
Why?
|
| Drug Design | 1 | 2016 | 63 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2016 | 257 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 344 | 0.030 |
Why?
|
| Models, Structural | 1 | 1993 | 13 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 24 | 0.030 |
Why?
|
| Probability | 1 | 1993 | 78 | 0.030 |
Why?
|
| Electricity | 1 | 1992 | 7 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1992 | 25 | 0.020 |
Why?
|
| Base Sequence | 1 | 1993 | 588 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 1056 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 37 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 269 | 0.020 |
Why?
|
| Thermotoga maritima | 1 | 2002 | 1 | 0.010 |
Why?
|
| Biophysics | 1 | 2002 | 14 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 2002 | 9 | 0.010 |
Why?
|
| Oocytes | 1 | 1999 | 24 | 0.010 |
Why?
|
| Xenopus | 1 | 1999 | 28 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1999 | 162 | 0.010 |
Why?
|
| Mitosis | 1 | 1999 | 115 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 64 | 0.010 |
Why?
|
| DNA Helicases | 1 | 1999 | 54 | 0.010 |
Why?
|